References

1. 1. Collins   FS. . Cystic fibrosis: molecular biology and therapeutic implications. . Science . 1992; ;256: : 774– – 876 .
   [Google Scholar]
2. 2. Stern   M., , Geddes   D. . Cystic fibrosis: basic chemical and cellular mechanisms. . Br J Hosp Med . 1996; ;55: : 237– – 240 .
   [Google Scholar]
3. 3. Tsui   LC. . The cystic fibrosis trans-membrane conductance regulator gene. . Am J Respir Crit Care Med . 1993; ;151: : S47– – S53 .
   [Google Scholar]
4. 4. Cystic Fibrosis Genetic Analysis Consortium CFTR Mutation Tabl, 2002. http://www.genet.sickkids.on.ca/cftr/.
5. 5. Welsh   MJ., , Tsui   I., , Boat   TF., , Beaudet   AL. . Cystic fibrosis. . In: Scriver   CR., Beaudet   AL., Slys   Valle D. , eds. The Metabolic and Molecular Bases of Inherited Disease . , 7th edition. . New York: : McGraw-Hill;   1995; ; : 3799– – 3876 .
   [Google Scholar]
6. 6. El Harith   EA., , Dork   T., , Stuhmann   M., , Stuhrmann   M., , Abu-Srair   H., , al-Shahri   A., , Keller   K M., , Lentze   MJ., , Schmidtke   J. . Novel and characteristic CFTR mutations in Saudi Arabian children with severe cystic fibrosis. . J Med Genet . 1997; ;34: : 996– – 999 .
   [Google Scholar]
7. 7. Abdul Wahab   A., , Al Thani   G., , Dawod   ST., , Kambouris   M., , Al Hamed   M. . Heterogeneity of the Cystic Fibrosis Phenotype in a Large Kindred Family in Qatar with Cystic Fibrosis Mutation {11234V). . J Trop Pediatr . 2001; ;47: : 110– – 112 .
   [Google Scholar]
8. 8. Rawashdeh   M., , Manal   H. . Cystic fibrosis in Arabs: a prototype from Jordan. . Ann Trop Pediatr . 2000; ;20: 4 : 283– – 286 .
   [Google Scholar]
9. 9. Desgeorges   M., , Megarbane   A., , Guittard   C., , Carles   S., , Loiselet   J., , Demaille   J., , Claustres   M. . Cystic fibrosis in Lebanon: distribution of CFTR mutation among Arab communities. . Hum Genet . 1997; ;100: 2 : 279– – 283 .
   [Google Scholar]
10. 10. Osborne   L., , Knight   R., , Santis   G., , Hodson   ME. . A mutation in the second nucleotide binding fold of the cystic fibrosis gene. . Am J Hum Genet . 1991; ;48: : 608– – 612 .
    [Google Scholar]
11. 11. Ko   YH., , Pedersen   PL:. . The first nucleotide binding fold of cystic fibrosis transmembrane conductance regulator can function as an active ATPase. . J Biol Chem . 1995; ;270: : 22093– – 22096 .
    [Google Scholar]
12. 12. Osborne   L., , Santis   G., , Schwarz   M., , Klinger   K., , Dork   T., , Mcintosh   I., , Nunes   V., , Macek   M Jr., , Reiss   J. , et al. , Incidence and expression of the the N1303K mutation of the cystic fibrosis (CFTR) gene. . Hum Genet.   1992; ;89: 6 : 653– – 658 .
    [Google Scholar]
13. 13. Banjar   H., , Kambouris   M., , Meyer   BF., , Al Mehaidib   A., , Mogarri   I. . Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia. . Ann Trop Pediatr . 1999; ;19: : 69– – 73 .
    [Google Scholar]
14. 14. Estivill   X., , Bancells   C., , Ramos   C. . Geographic distribution and regional origin of272 cystic fibrosis mutation in European populations. The Biomed CF Mutations Analysis Consortum. . Hum Mutat . 1997; ;10: 2 : 135– – 154 .
    [Google Scholar]
15. 15. Gottlieb   RP. . Metabolic alkalosis in cystic fibrosis. . J Pediatr . 1971; ;79: : 930– – 936 .
    [Google Scholar]
16. 16. Beckerman   RC., , Taussig   LM. . Hypoelectrolytaemia and mtabolic alkalosis in jnfants with cystic fibrosis. . Pediatrics . 1979; ; : 580– – 583 .
    [Google Scholar]
17. 17. Kessler   WR., , Anderson   DH:. . Heat prostration in fibrocystic disease of the pancreas and other conditions. . Pediatrics . 1951; ;8: : 648 .
    [Google Scholar]